1. PLK4: a promising target for cancer therapy

   • Yi Zhao
   • Xin Wang

   Review – Cancer Research 06 September 2019 Pages: 2413 - 2422

2. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population

   • Minghao Sun
   • Jie Liu
   • Xiaojun Zhou

   Original Article – Cancer Research 27 August 2019 Pages: 2423 - 2432

   

3. Stress-triggered YAP1/SOX2 activation transcriptionally reprograms head and neck squamous cell carcinoma for the acquisition of stemness

   • Hirofumi Omori
   • Kuniaki Sato
   • Muneyuki Masuda

   Original Article – Cancer Research 04 September 2019 Pages: 2433 - 2444

   

4. Meeting report of the 7th Heidelberg Myeloma Workshop: today and tomorrow

   • M. A. Baertsch
   • R. Lutz
   • H. Goldschmidt

   Original Article – Cancer Research 12 August 2019 Pages: 2445 - 2455

   

5. Wilms tumor-suppressing peptide inhibits proliferation and induces apoptosis of Wilms tumor cells in vitro and in vivo

   • Wei Zhao
   • Juan Li
   • Jiaxiang Wang

   Original Article – Cancer Research 28 August 2019 Pages: 2457 - 2468

   

6. Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis

   • Ciro Franzese
   • Lucia Di Brina
   • Marta Scorsetti

   Original Article – Cancer Research 23 August 2019 Pages: 2469 - 2479

   

7. Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours

   • Ylberta Kajtazi
   • Daniel Kaemmerer
   • Amelie Lupp

   Original Article – Cancer Research 26 August 2019 Pages: 2481 - 2493

   

8. Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified

   • Takahiro Ota
   • Keisuke Kirita
   • Koichi Goto

   Original Article – Cancer Research 07 September 2019 Pages: 2495 - 2506

   

9. METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy

   • Lin Xin
   • Qi Zhou
   • Chuan liu

   Original Article – Cancer Research 04 September 2019 Pages: 2507 - 2517

   

10. EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer

    • Bastian Czogalla
    • Christina Kuhn
    • Anna Hester

    Original Article – Cancer Research 04 September 2019 Pages: 2519 - 2527

    

11. PET/CT-based bone-marrow assessment shows potential in replacing routine bone-marrow biopsy in part of patients newly diagnosed with extranodal natural killer/T-cell lymphoma

    • Yiqin Wang
    • Li Xie
    • Ming Jiang

    Original Article – Clinical Oncology 04 September 2019 Pages: 2529 - 2539

    

12. Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

    • Mingjia Li
    • Daniel Spakowicz
    • Dwight H. Owen

    Original Article – Clinical Oncology Open access 31 July 2019 Pages: 2541 - 2546

    

13. Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients

    • Luca Nicosia
    • Rosario Mazzola
    • Filippo Alongi

    Original Article – Clinical Oncology 19 July 2019 Pages: 2547 - 2554

    

14. Correlation between the qualification for bevacizumab use and the survival of patients with non-small cell lung cancer harboring the epidermal growth factor receptor mutation: a retrospective analysis

    • Taiki Hakozaki
    • Yusuke Okuma
    • Yukio Hosomi

    Original Article – Clinical Oncology 26 July 2019 Pages: 2555 - 2564

    

15. Metastatic lymph node burden predictive of survival in patients undergoing primary surgery for laryngeal and hypopharyngeal cancer

    • Yeonjoo Choi
    • Manal Bin-Manie
    • Sang Yoon Kim

    Original Article – Clinical Oncology 27 July 2019 Pages: 2565 - 2572

    

16. Invasive stratified mucin-producing carcinoma (i-SMILE) of the uterine cervix: report of a case series and review of the literature indicating poor prognostic subtype of cervical adenocarcinoma

    • Lars-Christian Horn
    • Romy Handzel
    • Christine E. Brambs

    Original Article – Clinical Oncology 05 August 2019 Pages: 2573 - 2582

    

17. High-intensity interval training can modulate the systemic inflammation and HSP70 in the breast cancer: a randomized control trial

    • Ali Mohammad Alizadeh
    • Amin Isanejad
    • Zuhair Mohammad Hassan

    Original Article – Clinical Oncology 10 August 2019 Pages: 2583 - 2593

    

18. The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience

    • Malte Roerden
    • Juliane S. Walz
    • Wichard Vogel

    Original Article – Clinical Oncology 13 August 2019 Pages: 2595 - 2604

    

19. Metastatic location of extensive stage small-cell lung cancer: implications for thoracic radiation

    • Huaqi Zhang
    • Lei Deng
    • Jinming Yu

    Original Article – Clinical Oncology 13 August 2019 Pages: 2605 - 2612

    

20. Co-occurring genetic alterations predict distant metastasis and poor efficacy of first-line EGFR-TKIs in EGFR-mutant NSCLC

    • Li-Li Deng
    • Ge Gao
    • Yu Yang

    Original Article – Clinical Oncology 28 August 2019 Pages: 2613 - 2624

    

21. C-reactive protein as an early marker of immune-related adverse events

    • Amir-Reza Abolhassani
    • Gerold Schuler
    • Lucie Heinzerling

    Original Article – Clinical Oncology 06 September 2019 Pages: 2625 - 2631

    

22. Combining immunotherapy and natural immune stimulants: mechanisms and clinical implications

    • Khara Lucius
    • Jacob Hill

    Letter to the Editors 23 January 2019 Pages: 2633 - 2635